Evidence map›Paper›PMID 34137598›Full record

ArticleJournal of the American Chemical Society2021

Norstictic Acid Is a Selective Allosteric Transcriptional Regulator.

Julie M Garlick, Steven M Sturlis, Paul A Bruno, Joel A Yates, Amanda L Peiffer, Yejun Liu, Laura Goo, LiWei Bao, Samantha N De Salle, Giselle Tamayo-Castillo and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Drugging Fuzzy Complexes in Transcription.Frontiers in molecular biosciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Julie M GarlickLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Steven M SturlisLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Paul A BrunoLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Joel A YatesDepartment of Internal Medicine, Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
Amanda L PeifferLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Yejun LiuLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Laura GooDepartment of Internal Medicine, Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
LiWei BaoDepartment of Internal Medicine, Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
Samantha N De SalleLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Giselle Tamayo-CastilloCIPRONA and School of Chemistry, University of Costa Rica, 11501 San Jose, Costa Rica.ORCID 0000-0002-4912-8895
Charles L BrooksDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-8149-5417
Sofia D MerajverDepartment of Internal Medicine, Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States.
Anna K MappLife Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0003-0791-8327
University of Michigan · USUniversidad de Costa Rica · CR

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Theory and Modeling of Biomolecules and their Interactions - Equipment SupplementR35GM130587 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHARLES L BROOKS · 2019 to 2026
$6.9M
MICHIGAN CHEMISTRY-BIOLOGY INTERFACE TRAINING PROGRAMT32GM008597 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTGOMERY, JOHN · 1996 to 2018
$5.0M
Probing transcriptional activation at the molecular level - Equipment SupplementR35GM136356 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANNA K. MAPP · 2020 to 2026
$3.3M
CHARMM Modernization, Performance, and Continued DevelopmentR01GM103695 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, CHARLES L · 2012 to 2018
$3.1M
Computational infrastructure for biomedically-driven simulation and modelingS10OD034346 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BROOKS, CHARLES L · 2023 to 2023
$593k
NCI NIH HHS P30 CA046592NIGMS NIH HHS R01 GM103695NIGMS NIH HHS R35 GM130587NIGMS NIH HHS R35 GM136356NIGMS NIH HHS T32 GM008597NIH HHS S10 OD034346
6 · The paper itself

Abstract

Inhibitors of transcriptional protein-protein interactions (PPIs) have high value both as tools and for therapeutic applications. The PPI network mediated by the transcriptional coactivator Med25, for example, regulates stress-response and motility pathways, and dysregulation of the PPI networks contributes to oncogenesis and metastasis. The canonical transcription factor binding sites within Med25 are large (∼900 Å

Indexed as

Allosteric RegulationCell Line, TumorDNA-Binding ProteinsHumansLactonesMediator ComplexMolecular Dynamics SimulationProtein BindingProtein DomainsSalicylatesTranscription FactorsTranscription, GeneticDNA-Binding ProteinsETV5 protein, humanLactonesMED25 protein, humanMediator Complexnorstictic acidSalicylatesTranscription Factors

Identifiers

PMID34137598
PMCPMC8717358
OpenAlexW3165964501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.